Index was outside the bounds of the array. 文章摘要
|本期目录/Table of Contents|

[1]高飞,刘丹彦.非心脏手术后心肌损伤[J].国际心血管病杂志,2024,01:15-18.
点击复制

非心脏手术后心肌损伤(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2024年01期
页码:
15-18
栏目:
综述
出版日期:
2024-01-22

文章信息/Info

Title:
-
作者:
高飞; 刘丹彦
400016 重庆医科大学附属第一医院麻醉科
Author(s):
-
关键词:
外科手术; 心肌肌钙蛋白; 非心脏手术; 心肌损伤
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2024.01.005
文献标识码:
-
摘要:
非心脏手术后心肌损伤（MINS）定义为术后肌钙蛋白高于正常值，是术后重要 的并发症且发生率较高，易误诊、漏诊。冠状动脉斑块破裂和氧供需不匹配是其主要发生机 制，术前评估有助于识别高危患者，术中需维持适当的生命体征以降低心肌损伤发生，肌钙蛋 白检测有利于早期识别并及时干预。目前对于MINS 的治疗存在争议。该文主要介绍MINS 的定义、流行病学、病理生理、诊断及围术期管理。
Abstract:
-

参考文献/References

[1] Nepogodiev D, Martin J, Biccard B, et al. Global burden of postoperative death[J]. Lancet, 2019, 393(10170):401.
[2] Sellers D, Srinivas C, Djaiani G. Cardiovascular complications after non-cardiac surgery[J]. Anaesthesia, 2018, 73 Suppl 1:34- 42.
[3] 马丽媛, 王增武, 樊静, 等.《中国心血管健康与疾病报告 2021》概要[J]. 中国介入心脏病学杂志, 2022, 30(7):481-496.
[4] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal definition of myocardial infarction (2018)[J]. J Am Coll Cardiol, 2018, 72(18):2231-2264.
[5] Turan A, Cohen B, Rivas E, et al. Association between postoperative haemoglobin and myocardial injury after noncardiac surgery: a retrospective cohort analysis[J]. Br J Anaesth, 2021, 126(1):94-101.
[6] Biccard BM, Scott DJA, Chan MTV, et al. Myocardial injury after noncardiac surgery (MINS) in vascular surgical patients: a prospective observational cohort study[J]. Ann Surg, 2018, 268(2):357-363.
[7] Smilowitz NR, Redel-Traub G, Hausvater A, et al. Myocardial injury after noncardiac surgery: a systematic review and metaanalysis[ J]. Cardiol Rev, 2019, 27(6):267-273.
[8] Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-Day mortality among patients undergoing noncardiac surgery[J]. JAMA, 2017, 317(16):1642-1651.
[9] Smilowitz NR, Gupta N, Ramakrishna H, et al. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery[J]. JAMA Cardiol, 2017, 2(2):181-187.
[10] Devereaux PJ, Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management[J]. Eur Heart J, 2020, 41(32):3083-3091.
[11] Magoon R, Makhija N, Das D. Perioperative myocardial injury and infarction following non-cardiac surgery: a review of the eclipsed epidemic[J]. Saudi J Anaesth, 2020, 14(1):91-99.
[12] Smit M, Coetzee AR, Lochner A. The pathophysiology of myocardial ischemia and perioperative myocardial infarction[J]. J Cardiothorac Vasc Anesth, 2020, 34(9):2501-2512.
[13] Gualandro DM, Puelacher C, Lurati Buse G, et al. Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I[J]. Clin Res Cardiol, 2021, 110(9):1450-1463.
[14] Ruetzler K, Smilowitz NR, Berger JS, et al. Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American Heart Association[J]. Circulation, 2021, 144(19):e287-e305.
[15] Moraes CMT, Corrêa LM, Procópio RJ, et al. Tools and scores for general and cardiovascular perioperative risk assessment: a narrative review[J]. Rev Col Bras Cir, 2022, 49:e20223124.
[16] Duceppe E, Patel A, Chan MTV, et al. Preoperative N-terminal pro-B-type natriuretic peptide and cardiovascular events after noncardiac surgery: a cohort study[J]. Ann Intern Med, 2020, 172(2):96-104.
[17] Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis[J]. J Am Coll Cardiol, 2014, 63(2):170-180.
[18] Duceppe E, Parlow J, MacDonald P, et al. Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery[J]. Can J Cardiol, 2017, 33(1):17-32.
[19] Punthakee Z, Iglesias PP, Alonso-Coello P, et al. Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study[J]. Lancet Diabetes Endocrinol, 2018, 6(10):790-797.
[20] Meershoek AJA, Leunissen TC, van Waes JAR, et al. Reticulated platelets as predictor of myocardial injury and 30 day mortality after non-cardiac surgery[J]. Eur J Vasc Endovasc Surg, 2020, 59(2):309-318.
[21] Ackland GL, Abbott TEF, Cain D, et al. Preoperative systemic inflammation and perioperative myocardial injury: prospective observational multicentre cohort study of patients undergoing non-cardiac surgery[J]. Br J Anaesth, 2019, 122(2):180-187.
[22] Kwon JH, Park J, Lee SH, et al. Pre-operative anaemia and myocardial injury after noncardiac surgery: a retrospective study[J]. Eur J Anaesthesiol, 2021, 38(6):582-590.
[23] Devereaux PJ, Yang H, Yusuf S, et al. Effects of extendedrelease metoprolol succinate in patients undergoing non-cardiac surgery(POISE trial): a randomised controlled trial[J]. Lancet, 2008, 371(9627):1839-1847.
[24] Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery[J]. Eur Heart J, 2022, 43(39):3826-3924.
[25] Kertai MD, Cooter M, Pollard RJ, et al. Is compliance with surgical care improvement project cardiac (SCIP-Card-2) measures for perioperative β-Blockers associated with reduced incidence of mortality and cardiovascular-related critical quality indicators after noncardiac surgery?[J]. Anesth Analg, 2018, 126(6):1829-1838.
[26] Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery[J]. N Engl J Med, 2014, 370(16):1494-1503.
[27] Berwanger O, Le Manach Y, Suzumura EA, et al. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study[J]. Eur Heart J, 2016, 37(2):177-185.
[28] Berwanger O, de Barros E Silva PG, Barbosa RR, et al. Atorvastatin for high-risk statin-na?ve patients undergoing noncardiac surgery: the Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial[J]. Am Heart J, 2017, 184:88-96.
[29] Salmasi V, Maheshwari K, Yang DS, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis[J]. Anesthesiology, 2017, 126(1):47-65.
[30] Sessler DI, Meyhoff CS, Zimmerman NM, et al. Perioddependent associations between hypotension during and for four days after noncardiac surgery and a composite of myocardial infarction and death: a substudy of the POISE-2 Trial[J]. Anesthesiology, 2018, 128(2):317-327.
[31] Wanner PM, Wulff DU, Djurdjevic M, et al. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery[J]. J Am Coll Cardiol, 2021, 78(18):1753-1764.
[32] Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and shortterm prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study[J]. Ann Intern Med, 2011, 154(8):523-528.

备注/Memo

备注/Memo:
基金项目：卫生部国家临床重点专科建设项目[财社（ 2011） 170号]； 重庆市医学重点学科[ 渝卫科教（2007）2 号]
通信作者：刘丹彦， E-mail：liudanyan418@qq.com
更新日期/Last Update: 2024-01-22